Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Title:||The (S)-enantiomer of 2-hydroxysaclofen is the active GABAB receptor antagonist in central and peripheral preparations|
|Citation:||European Journal of Pharmacology, 1995; 287(2):185-189|
|Abstract:||In the guinea-pig isolated ileum, (RS)-(+/-)-baclofen induced a depression of cholinergic twitch contractions, reversibly and competitively antagonised by (S)-2-hydroxysaclofen (pA2 = 5.2 +/- 0.2), but not by (R)-2-hyroxysaclofen. The depression of excitatory field potentials by baclofen ( 5 mu M) in rat CA1 hippocampal slices was antagonised by (S)-2-hydroxysaclofen (100 mu m) (pA2 = 4.3), whilst in rat neocortex, (S)-2-hyroxysaclofen (50-500 mu M) antagonised the baclofen (10 mu M)-induced suppression of spontaneous discharges, the (R)-enantiomer being inactive. These results show that (S)-2-hydroxysaclofen is the active antagonist at central and peripheral GABAB receptors.|
|Keywords:||GABAB receptor; (RS)-(±)-Baclofen; (S)-2-Hydroxysaclofen; (R)-2-Hydroxysaclofen; Ileum, guinea pig; Hippocampus, rat; Neocortex, rat|
|Rights:||© 1995 Elsevier Science B.V. All rights reserved|
|Appears in Collections:||Anaesthesia and Intensive Care publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.